Intervention Protocol

Alpha-lipoic acid for diabetic peripheral neuropathy

  1. Nasir Mirza1,*,
  2. David R Cornblath2,
  3. Syed Hasan1,
  4. Usman Hussain1

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 19 OCT 2005

DOI: 10.1002/14651858.CD005492


How to Cite

Mirza N, Cornblath DR, Hasan S, Hussain U. Alpha-lipoic acid for diabetic peripheral neuropathy (Protocol). Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD005492. DOI: 10.1002/14651858.CD005492.

Author Information

  1. 1

    National Hospital for Neurology and Neurosurgery, c/o Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Disease, London, UK

  2. 2

    Johns Hopkins Hospital, Department of Neurology, Baltimore, Maryland, USA

*Nasir Mirza, c/o Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, PO Box 114, Queen Square, London, WC1N 3BG, UK. nasir.mirza@doctors.org.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 OCT 2005

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Gerritje S. Mijnhout, Boudewijn J. Kollen, Alaa Alkhalaf, Nanno Kleefstra, Henk J. G. Bilo, Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials, International Journal of Endocrinology, 2012, 2012, 1

    CrossRef

  2. 2
    Alexander FJE Vrancken, Ivo N van Schaik, Richard AC Hughes, Nicolette C Notermans, Drug therapy for chronic idiopathic axonal polyneuropathy, The Cochrane Library,